ConductScience.org, home

Gene · 8805

TRIM24: tripartite motif containing 24

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. TRIM24: tripartite motif containing 24. Genes, record 8805. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8805

On this page

Gene

Symbol
TRIM24
HGNC
Name
tripartite motif containing 24
HGNC
NCBI Gene ID
8805
NCBI Gene
HGNC ID
HGNC:11812
HGNC
Ensembl
ENSG00000122779
NCBI Gene
Aliases
PTC6, RNF82, TF1A, TIF1, TIF1A, TIF1ALPHA, Tif1a, hTIF1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O15164Transcription intermediary factor 1-alpha1,05022Ensembl, GeneID, HGNC

Source UniProt

Patents39

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-196543O15164Espacenet
EP 4641201 A22025-10-296293O15164Espacenet
JP 2025147176 A2025-10-0613746O15164Espacenet
JP 2025529142 A2025-09-047969O15164Espacenet
US 12371689 B22025-07-297969O15164Espacenet
JP 2025517969 A2025-06-126293O15164Espacenet
JP 2025517970 A2025-06-126543O15164Espacenet
JP 2025028160 A2025-02-2813746O15164Espacenet
KR 1020250010750 A2025-01-2113746O15164Espacenet
JP 2024161501 A2024-11-1948O15164Espacenet

1 to 10 of 39

See all 39 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,089

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleTRIM24 papersNewest fiscal year
P30CA016672Cancer Center Support Grant242025
P30CA008748Cancer Center Support Grant182025
ZIAES101074Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease162025
ZIAAR041203Muscle Disease Unit102025
P50CA092629SPORE in Prostate Cancer52025
R01CA193837Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence52025
ZIAES101081Assessment, Therapy and Prevention Of Autoimmune Disease52025
R35CA197589Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities42025
P01CA066996Development of Novel Therapeutic Strategies in Human Leukemias32025
P30CA010815Consolidated Basic Cancer Research Program32025

1 to 10 of 1,089Source NIH's project files

See all 1,089 nih grants

Papers1,935

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Retraction Note: Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.J Exp Clin Cancer Res202642823698PubTator, text miningPubMed
MOV10 inhibits SADS-CoV replication by enhancing TRIM24-mediated K63-linked TRAF3 ubiquitination, and this inhibition is antagonized by viral N protein.J Virol202642808732PubTator, text miningPubMed
Selective remodeling of snoRNA and sdRNA biology in glioblastoma.Front Cell Dev Biol202642750837PubTator, text miningPubMed
Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output.Cold Spring Harb Perspect Biol202642575696PubTator, text miningPubMed
BRAF fusions define therapeutic vulnerability and tyrosine kinase inhibitor resistance in non-small cell lung cancer.Lung Cancer202642546514PubTator, text miningPubMed
Prognostic value of TRIM24 expression in gastric cancer and various human solid tumours: a comprehensive cross-sectional, and meta-analysis study.Prz Gastroenterol202642483627PubTator, text miningPubMed
TRERNA1-mediated acetylation represses ferroptosis of non-small cell lung cancer cells via the KAT6A/H3K23ac/TRIM24-PIK3CA pathway.Hum Cell202642340519PubTator, text miningPubMed
Bioorthogonal release-mediated targeted degradation of tripartite motif containing 24 protein for atherosclerosis therapy.J Control Release202642323020PubTator, text miningPubMed
TRIM24 in Human Cancers: A Dual-Function Oncoprotein, Regulatory Mechanisms, and Emerging Therapeutic Strategies.Int J Cancer202642290584PubTator, text miningPubMed
TIF1 Family Proteins as Modulators of Cell Death: Mechanisms and Therapeutic Opportunities.Biomolecules202642194066PubTator, text miningPubMed

1 to 10 of 1,935

See all 1,935 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/8805

GET https://conductscience.org/api/genes/v1/8805/patents?page=2